Diacerein: A potential therapeutic drug for periodontal disease

Medical Hypotheses

Volumn 79, Issue 2, 2012, Pages 165-167

  Huang, Ren Yeong ^a,b   Lu, Sheng Hua ^b   Su, Kwan Wei ^b   Chen, Jen Kun ^c   Fang, Wen Hui ^a   Liao, Wei Neng ^c   Chen, Sih Yu ^c   Shieh, Yi Shing ^a,b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS1 PROTEIN; ANTHRAQUINONE DERIVATIVE; BACTERIAL POLYSACCHARIDE; CYCLOOXYGENASE 2; CYTOKINE; DIACEREIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; MESSENGER RNA; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC DISEASE; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION; GINGIVA; HISTOLOGY; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY DISEASE; MALE; NONHUMAN; OSTEOARTHRITIS; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS; CASPASE 1; HUMANS; INTERLEUKIN-1; MODELS, IMMUNOLOGICAL; PERIODONTAL DISEASES; PERIODONTIUM;

EID: 84863307922     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.04.024     Document Type: Article

References (28)

1. Bartold P.M., Cantley M.D., Haynes D.R. Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000, 53:55-69.
2. Amano A. Host-parasite interactions in periodontitis: subgingival infection and host sensing. Periodontol 2000, 52:7-11.
3. Hunter D.J., Wise B. Review diacerein is more effective than placebo and is as effective as NSAIDs for knee and hip osteoarthritis. Evid Based Med 2007, 12:74.
4. Pujol J.P., Felisaz N., Boumediene K., Ghayor C., Herrouin J., Bogdanowicz P., et al. Effects of diacerein on biosynthesis activities of chondrocytes in culture. Biorheology 2000, 37:177-184.
5. Brandt K.D. Studies in animal models of osteoarthritis as predictors of a structure-modifying effect of diacerhein in humans with osteoarthritis. Biorheology 2006, 43:589-594.
6. Domagala F., Martin G., Bogdanowicz P., Ficheux H., Pujol J.P. Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for Diacerein effects in osteoarthritis. Biorheology 2006, 43:577-587.
7. Alvarez-Soria M.A., Herrero-Beaumont G., Sanchez-Pernaute O., Bellido M., Largo R. Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast - comparison to its effects on osteoarthritic chondrocytes. Rheumatology (Oxford) 2008, 47:627-633.
8. Bartels E.M., Bliddal H., Schondorff P.K., Altman R.D., Zhang W., Christensen R. Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage 2010, 18:289-296.
9. Koide M., Suda S., Saitoh S., Ofuji Y., Suzuki T., Yoshie H., et al. In vivo administration of IL-1 beta accelerates silk ligature-induced alveolar bone resorption in rats. J Oral Pathol Med 1995, 24:420-434.
10. Gaspersic R., Stiblar-Martincic D., Osredkar J., Skaleric U. Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 2003, 38:198-203.
11. Cochran D.L. Inflammation and bone loss in periodontal disease. J Periodontol 2008, 79:1569-1576.
12. Dinarello C.A. IL-1: discoveries, controversies and future directions. Eur J Immunol 2010, 40:599-606.
13. Graves D.T., Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003, 74:391-401.
14. Waykole Y.P., Doiphode S.S., Rakhewar P.S., Mhaske M. Anticytokine therapy for periodontal diseases: where are we now?. J Indian Soc Periodontol 2009, 13:64-68.
15. Tamura T., Kosaka N., Ishiwa J., Sato T., Nagase H., Rhein Ito A. an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes. Osteoarthritis Cartilage 2001, 9:257-263.
16. Verbruggen G. Chondroprotective drugs in degenerative joint diseases. Rheumatology (Oxford) 2006, 45:129-138.
17. Moldovan F., Pelletier J.P., Jolicoeur F.C., Cloutier J.M., Martel-Pelletier J. Diacerhein and rhein reduce the ICE-induced IL-1beta and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000, 8:186-196.
18. Mian M., Trombi L., Rosini S., Benetti D., Caracciolo F., Carulli G., et al. Experimental studies on diacerhein: effects on the phagocytosis of neutrophil cells from subcutaneous carrageenan-induced exudate. Drugs Exp Clin Res 1987, 13:695-698.
19. Wang L., Mao Y.J., Wang W.J. Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action. Yao Xue Xue Bao 2006, 41:555-560.
20. Boileau C., Tat S.K., Pelletier J.P., Cheng S., Martel-Pelletier J. Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling. Arthritis Res Ther 2008, 10:R71.
21. Pelletier J.P., Lajeunesse D., Reboul P., Mineau F., Fernandes J.C., Sabouret P., et al. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone. J Rheumatol 2001, 28:814-824.
22. Falgarone G., Dougados M. Diacerein as a disease-modulating agent in osteoarthritis. Curr Rheumatol Rep 2001, 3:479-483.
23. Cheng W.C., Huang R.Y., Chiang C.Y., Chen J.K., Liu C.H., Chu C.L., et al. Ameliorative effect of quercetin on the destruction caused by experimental periodontitis in rats. J Periodontal Res 2010, 45:788-795.
24. Ohuchi N., Hayashi K., Iwamoto K., Koike K., Kizawa Y., Nukaga M., et al. Thrombin-stimulated proliferation is mediated by endothelin-1 in cultured rat gingival fibroblasts. Fundam Clin Pharmacol 2010, 24:501-508.
25. Choi H., Lim W., Kim I., Kim J., Ko Y., Kwon H., et al. Inflammatory cytokines are suppressed by light-emitting diode irradiation of P. gingivalis LPS-treated human gingival fibroblasts: inflammatory cytokine changes by LED irradiation. Lasers Med Sci 2011, 27:459-467.
26. Susilowati H., Santoso A.L., Barid I., Sosroseno W. Rat periodontal fibroblast responses to bacterial lipopolysaccharide in vitro. J Microbiol Immunol Infect 2002, 35:203-206.
27. Yu S., Li H., Ma Y., Fu Y. Matrix metalloproteinase-1 of gingival fibroblasts influenced by advanced glycation end products (AGEs) and their association with receptor for AGEs and nuclear factor-kappaB in gingival connective tissue. J Periodontol 2012, 83:119-126.
28. Kim H.K., Park H.R., Lee J.S., Chung T.S., Chung H.Y., Chung J. Down-regulation of iNOS and TNF-alpha expression by kaempferol via NF-kappaB inactivation in aged rat gingival tissues. Biogerontology 2007, 8:399-408.